NORDITROPIN FLEXPRO (somatropin) by Novo Nordisk. Approved for recombinant human growth hormone [epc]. First approved in 2000.
Drug data last refreshed 19h ago · AI intelligence enriched 1w ago
NORDITROPIN FLEXPRO is a recombinant human growth hormone (somatropin) administered via subcutaneous injection. It is indicated for growth hormone deficiency and related growth disorders in pediatric and adult populations. The drug replaces or supplements endogenous growth hormone to promote normal growth, metabolism, and body composition.
With LOE approaching and moderate commercial spending, the NORDITROPIN brand team faces transition planning and likely workforce restructuring as market exclusivity erodes.
Recombinant Human Growth Hormone
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
The Efficacy and Safety of Inpegsomatropin Injection in Children With Turner Syndrome (TS) and Short Stature
Safety, Pharmacokinetic (PK) Profile and Efficacy of Inpegsomatropin Injection in Adults With Growth Hormone Deficiency
A Study to Learn How Different Injector Pens Affect the Study Medicine Called Genotropin (Somatropin) Delivery and Taken up Into the Blood in Healthy Adults
The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational Age
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Worked on NORDITROPIN FLEXPRO at Novo Nordisk? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moNovo Nordisk is hiring 2 roles related to this product
Roles linked to NORDITROPIN FLEXPRO skew toward regulatory, biostatistical, and clinical science functions, reflecting mature product lifecycle and compliance/publication priorities over commercial expansion. This profile suggests career opportunities in regulatory strategy, data management, and medical affairs rather than sales or launch roles.
8 open roles linked to this drug